Artículos publicados 2022-2023

Servicio de Nefrología

    • Frutos MÁ, Crespo M, Valentín MO, González E, Pascual J. Recommendations for living donor kidney transplantation. Nefrologia. 2022 42 Suppl 2:5-132. [doi:10.1016/j.nefroe.2022.07.001]
    • Redondo, N, Rodriguez-Goncer, I, Parra, P, González, E, Sevillano, A, Andrés, A, Fernandez-Ruiz, M. Impact of polymorphisms in genes orchestrating innate immune responses on replication kinetics of Torque teno virus after kidney transplantation. Frontiers in Genetics. 2022 13:1069890-1069890. [doi:10.3389/fgene.2022.1069890]
    • Carriazo S, Aparicio-Madre MI, Tornero-Molina F, Gutiérrez-Martínez E, Ortiz A. Impact of different COVID-19 waves on kidney replacement therapy epidemiology and mortality: REMER 2020. Nephrology Dialysis Transplantation. 2022 37(11):2253-2263. [doi:10.1093/ndt/gfac234]
    • Caravaca-Fontán F, Lucientes L, Serra N, Cavero T, Praga M. C3 glomerulopathy associated with monoclonal gammopathy: impact of chronic histologic lesions and beneficial effects of clone-targeted therapies. Nephrology Dialysis Transplantation. 2022 37(11):2128-2137. [doi:10.1093/ndt/gfab302]
    • Villanego, F, Mazuecos, A, Cubillo, B, González, E, Pascual, J. Treatment with sotrovimab for SARS-CoV-2 infection in a cohort of high-risk kidney transplant recipients Clinical kidney journal. 2022 15(10):1847-1855. [doi:10.1093/ckj/sfac177]
    • Sandino J, Martín-Taboada M, Medina-Gómez G, Vila-Bedmar R, Morales E. Novel Insights in the Physiopathology and Management of Obesity-Related Kidney Disease. Nutrients. 2022 14(19). [doi:10.3390/nu14193937]
    • Morales, E, Galindo, M. SGLT2 inhibitors in lupus nephropathy, a new therapeutic strategy for nephroprotection. Annals Of The Rheumatic Diseases. 2022. 81(9):1337-1338. [doi:10.1136/annrheumdis-2022-222512]
    • Caravaca-Fontán F, Rivero M, Cavero T, Praga M. Development and validation of a nomogram to predict kidney survival at baseline in patients with C3 glomerulopathy. Clinical kidney journal. 2022. 15(9):1737-1746. [doi:10.1093/ckj/sfac108]
    • Redondo N, Rodríguez-Goncer I, Parra P, González E, Polanco N, Trujillo H, Hernández A, Andrés A, Fernández-Ruiz M. Influence of single-nucleotide polymorphisms in TLR3 (rs3775291) and TLR9 (rs352139) on the risk of CMV infection in kidney transplant recipients. Frontiers in immunology. 2022 13:929995-929995. [doi:10.3389/fimmu.2022.929995]
    • Redondo N, Rodríguez-Goncer I, Parra P, González E, Hernández A, Trujillo H, Andrés A, Fernández-Ruiz M.  Genetic polymorphisms in TLR3, IL10 and CD209 influence the risk of BK polyomavirus infection after kidney transplantation. Scientific Reports. 2022 12(1):11338-11338. [doi:10.1038/s41598-022-15406-0]
    • Martinez-Montoro, JI, Morales, E, Cornejo-Pareja, I, Tinahones, FJ, Fernandez-Garcia, JC. Obesity-related glomerulopathy: Current approaches and future perspectives. Obesity Reviews. 2022 23(7). [doi:10.1111/obr.13450]
    • Caravaca-Fontán F, Díaz-Encarnación M, Cabello V, Praga M. Longitudinal change in proteinuria and kidney outcomes in C3 glomerulopathy. Nephrology Dialysis Transplantation. 2022 37(7):1270-1280. [doi:10.1093/ndt/gfab075]
    • Aubert, L, Sandino, J, Gutierrez-Solis, E, Garcia-Martin, F, Segura, J, Porrini, E, Morales, E. Role of non-alcoholic fatty liver disease in the evolution of renal function in patients with diabetes mellitus. Nephrology Dialysis Transplantation. 2022 37(6):1125-1131.[doi:10.1093/ndt/gfab176]
    • Lledó GM, Xipell M, García-Herrera A, Morales E, Praga M, Quintana LF. Saving the kidneys in the lupus patient: Beyond immunosuppression, the need to collaborate across multiple disciplines. European Journal Of Internal Medicine. 2022 99:19-21. [doi:10.1016/j.ejim.2022.03.016]
    • Sandino J, Cordero García-Galán L, Aubert Girbal L, Praga M, Pascual J, Morales E. Anything New in the Treatment of Obesity in Obese Patients with CKD? Nephron. 2022 146(6):616-623. [doi:10.1159/000524201]
    • Trujillo H, Sandino J, Cavero T, Caravaca-Fontán F, Gutiérrez E, Sevillano ÁM, Praga M. IgA Nephropathy Is the Most Common Underlying Disease in Patients With Anticoagulant-Related Nephropathy. Kidney International Reports. 2022 7(4):831-840. [doi:10.1016/j.ekir.2022.01.1048]
    • Rodríguez-Goncer I, Corbella L, Lora D, Gutiérrez E, Sevillano Á, Hernández Vicente A, González E, Andrés A, Fernández-Ruiz M. Role of cytomegalovirus infection after kidney transplantation on the subsequent risk of atherosclerotic and thrombotic events. Atherosclerosis Plus. 2022 48:37-46. [doi:10.1016/j.athplu.2022.03.003]
    • Huerta A, Mérida E, Medina L, Gutiérrez E, Hernández E, Sevillano A, Praga M. Corticosteroids and mycophenolic acid analogues in immunoglobulin A nephropathy with progressive decline in kidney function. Clinical kidney journal. 2022 15(4):771-777. [doi:10.1093/ckj/sfab244]
    • Scolari F, Alberici F, Mescia F, Delbarba E, Trujillo H, Praga M, Ponticelli C. Therapies for Membranous Nephropathy: A Tale From the Old and New Millennia. Frontiers in immunology. 2022 13:789713-789713. [doi:10.3389/fimmu.2022.789713]
    • Waldman, M, Soler, MJ, Garcia-Carro, C, Morales, E, Gutiérrez, E, Cravedi, P. COVID-19 in Patients with Glomerular Disease: Follow-Up Results from the IRoc-GN International Registry. Kidney360. 2022 3(2):293-306. [doi:10.34067/KID.0006612021]
    • Rodríguez-Goncer I, Ruiz-Ruigómez M, López-Medrano F, Trujillo H, González E, Polanco N, Gutiérrez E, Andrés A, Fernández-Ruiz M. Cytomegalovirus Exposure and the Risk of Overall Infection After Kidney Transplantation: A Cohort Study on the Indirect Effects Attributable to Viral Replication. Transplant International. 2022 35:10273-10273. [doi:10.3389/ti.2021.10273]
    • Navarro-García JA, Salguero-Bodes R, González-Lafuente L, Bada-Bosch T, Hernández E, Mérida-Herrero E, Praga M, Ruilope LM, Ruiz-Hurtado G. The anti-aging factor Klotho protects against acquired long QT syndrome induced by uremia and promoted by fibroblast growth factor 23. BMC Medicine. 2022 20(1):14-14. [doi:10.1186/s12916-021-02209-9]
    • Caravaca-Fontan, F, Polanco, N, Praga, M. Recurrence of immune complex and complement-mediated membranoproliferative glomerulonephritis in kidney transplantation. Nephrology Dialysis Transplantation. 2023 38(1):222-235. [doi:10.1093/ndt/gfac148]
    • Cavero T, Auñón P, Caravaca-Fontán F, Trujillo H, Morales E, Praga M. Thrombotic microangiopathy in patients with malignant hypertension. Nephrology Dialysis Transplantation. 2023 May 4;38(5):1217-1226. [doi: 10.1093/ndt/gfac248]
    • Zamarrón E, Jaureguizar A, García-Sánchez A, Díaz-Cambriles T, Alonso-Fernández A, Lores V, Mediano O, Troncoso-Acevedo F, Cabello-Pelegrín S, Morales-Ruíz E, Ramírez-Prieto MT, Valiente-Díaz MI, Gómez-García T, Casitas R, Martínez-Cerón E, Galera R, Cubillos-Zapata C, García-Río F. Continuous Positive Airway Pressure Effect on Albuminuria Progression in Patients with Obstructive Sleep Apnea and Diabetic Kidney Disease: A Randomized Clinical Trial. Am J Respir Crit Care Med. 2023 Mar 15;207(6):757-767. doi: 10.1164/rccm.202206-1091OC. 
    • Berzal R, Agredano B, Gil M, Galindo M, Morales E. mTOR inhibitors in a patient with lupus nephritis; why not?. Nefrologia (Engl Ed). 2022 Dec 21:S2013-2514(22)00175-4. doi: 10.1016/j.nefroe.2022.03.009.
    • Rodríguez-Almaraz E, Gutiérrez-Solís E, Rabadán E, Rodríguez P, Alonso M, Carmona L, de Yébenes MJG, Morales E, Galindo-Izquierdo M. Searching for a prognostic index in lupus nephritis. Eur J Med Res. 2023 Jan 11;28(1):19. doi: 10.1186/s40001-022-00946-y.
    • Lledó GM, Xipell M, García-Herrera A, Bueno L, Cervera R, Galindo M, Gómez-Puerta JA, Morales E, Praga M, Rojas JE, Ruiz-Irastorza G, Pernaute OS, Jayne D, Espinosa G, Quintana LF; Multidisciplinary Group for the Study of Lupus Nephritis. Saving the kidneys in the lupus patient: Beyond immunosuppression, the need to collaborate across multiple disciplines. Eur J Intern Med. 2022 May;99:19-21. doi: 10.1016/j.ejim.2022.03.016. Epub 2022 Mar 19.
    • González-Cuadrado C, Caro-Espada PJ, Chivite-Lacaba M, Utrero-Rico A, Lozano-Yuste C, Gutierrez-Solis E, Morales E, Sandino-Pérez J, Gil-Etayo FJ, Allende-Martínez L, Laguna-Goya R, Paz-Artal E. Hemodialysis-Associated Immune Dysregulation in SARS-CoV-2-Infected End-Stage Renal Disease Patients. Int J Mol Sci. 2023 Jan 15;24(2):1712. doi: 10.3390/ijms24021712.